Otros idiomas Biodesix, Inc.

Acciones

BDSX

US09075X1081

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1,31 ^USD	+4,80 %		+3,97 %	-28,80 %

05/04	Principales caídas del mediodía	MT
25/03	Biodesix alcanza un nuevo acuerdo de investigación con el Memorial Sloan Kettering Cancer Center	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024	24/04
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting	09/04
Biodesix, Inc. announced that it has received $34.999422 million in funding	09/04
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	08/04
Top Midday Decliners	05/04
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	05/04
Biodesix, Inc. announced that it expects to receive $34.999422 million in funding	05/04
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25/03
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center	25/03
Biodesix Announces New Master Collaborative Research Agreement with Memorial Sloan Kettering Cancer Center	25/03
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	04/03
Biodesix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/03
Biodesix, Inc. Provides Revenue Guidance for the Year 2024	01/03
Earnings Flash (BDSX) BIODESIX Posts Q4 Revenue $14.7M	01/03
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	01/03
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference	26/02
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024	16/02
Biodesix : New Financial Obligation - Form 8-K	20/12
Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method	15/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Biodesix, Inc.

Acciones

BDSX

US09075X1081

Otros idiomas

Filtros